ShineCare Unveils Next-Gen Digital Chronic Disease Management Platform 'Yao Health' Ahead of IPO

As China’s population ages at an accelerating pace, the prevalence of chronic diseases such as cardiovascular and cerebrovascular disorders continues to rise, with a marked trend toward affecting younger individuals. Therefore, within the macro context of the “Healthy China 2030” Planning Outline, some innovators are beginning to move beyond traditional management models in search of optimal medical solutions for chronic diseases.

Headquartered in Shanghai and deeply rooted in the Yangtze River Delta, Sinopharm Healthcare (Yao Ying Medical) is a high-quality medical chain institution. Adhering to the service philosophy of "patient-centered care," it provides customers with internationally advanced medical technologies and compassionate, humanistic services. Currently, Sinopharm Healthcare has successively established hospitals and multiple outpatient clinics in cities such as Shanghai, Hangzhou, and Suzhou, serving an expanding customer base.

Over the past seven years, SinoUnited Health has continuously pursued transformation and innovation, proactively embracing the wave of digital healthcare by establishing an internet hospital, upgrading to intelligent hospital management, and launching a new generation of digital chronic disease management products in 2023.

June 16, 2023，Hosted by Shanghai United Family Healthcare, the launch event for next-generation chronic disease management products and the inaugural Medical Service Innovation Summit, themed “Innovation in All Things, People-Centered Care,” will be grandly held on the Bund in Shanghai.

On the day of the forum, Singula Health’s WeChat Channels and VCBeat’s WeChat Channels will provide live streaming. You can scan the QR code in the image to reserve your spot for viewing.

Shine Medical’s New-Generation Chronic Disease Management Product, Built on Years of Expertise"Yao Health"It will be prominently launched at this conference, adopting a patient-centric approach that directly addresses the most critical pain points in chronic disease management. Based on the current state of the digital chronic disease management market, VCBeat identifies three key highlights of “Yao Health” that are worth anticipating:

First, it addresses the core demands of patients with chronic diseases—improving treatment outcomes and enhancing the healthcare experience. This also serves as the benchmark for assessing whether digital chronic disease management products are truly patient-centered.

First, improving treatment efficacy means curing or effectively controlling the condition of patients with chronic diseases to prevent further deterioration. Based on this principle, SinoUnited Health assembles a professional medical team to provide collaborative patient management. Recognizing that many patients with chronic conditions suffer from multiple comorbidities, SinoUnited Health employs a multidisciplinary, multi-team approach to jointly manage these cases, enabling the development of more comprehensive and personalized chronic disease management services tailored to each patient’s specific condition.

Secondly, chronic disease management is a continuous process that requires frequent interaction between patients and healthcare providers (doctors, hospitals, and pharmacies), resulting in a relatively poor patient experience within traditional medical settings. Leveraging its own hospitals and outpatient clinics, SingHealth Medical utilizes a digital platform to offer services such as rapid appointment scheduling, inpatient care, online prescription refills for chronic conditions, and home medication delivery, thereby enhancing patient satisfaction.

Second, the integration of software and hardware products enables comprehensive collection of users’ medical data, laying the technological foundation for sustainable chronic disease management.

Shine Medical, through its “wearable devices + patient management services + patient management SaaS platform,” accurately collects continuous health data from patients (such as blood pressure, blood glucose, blood lipids, heart rate, and electrocardiogram), analyzes their physical condition based on this data, and provides personalized chronic disease management solutions.This is the “From Data to Decision” framework proposed by SinoUnited Health, which delivers high-quality healthcare to patients by making chronic disease management safer, more effective, efficient, and timely, thereby truly achieving patient-centered care.

Furthermore, Shadow Medical collects continuous patient data, which not only optimizes the quality of medical services and enhances patient satisfaction but also reduces hospital management costs and serves as a tool for physicians to improve their work efficiency.

Third, the integration of online platforms with offline institutions enhances patient adherence, addressing the greatest challenge in chronic disease management.

Many patients with chronic diseases exhibit low adherence to disease management due to factors such as lifestyle habits and the level of attention paid to their conditions; therefore, external interventions are necessary to facilitate behavioral changes, making patient education and follow-up monitoring essential measures for improving adherence.

First, Singula Health conducts patient education to raise awareness of the urgency and necessity of chronic disease control and demonstrates the efficacy of its products. Patients can monitor their health status in real time through Singula Health’s digital chronic disease management platform. Second, through tracking and supervision, Singula Health leverages external tools such as its digital platform to encourage patients to modify personal habits. For instance, the Singula Health team intervenes in condition monitoring, implements follow-up management, and develops personalized diagnosis and treatment plans, providing comprehensive oversight throughout the entire process.

The aforementioned two points also imply that chronic disease management requires an integration of online and offline approaches. Physical, offline entities play a crucial role in supervision, guidance, and coordination with other medical services; therefore, rigorous and effective chronic disease management programs must be grounded in offline operations.This is also one of the key distinctions between SinoUnited Health and other digital health management vendors. With hospitals and outpatient clinics established in multiple locations, SinoUnited Health is fully equipped to deliver all online services.

From internet hospitals to intelligent hospital management, and further to next-generation digital products for chronic disease management, SinoUnited Health has consistently upheld the original aspirations and convictions of medical practitioners. By centering on patient needs, it has developed a series of digital products that serve as industry milestones.

At this press conference, relevant executives from SinoUnited Health will provide an in-depth analysis of the key advantages, technical capabilities, and scenario-based applications of “SinoHealth,” supported by real-world case studies. We look forward to witnessing the official launch of SinoUnited Health’s “SinoHealth” together with you!

As a key segment of the conference, an industry forum on healthcare service innovation will also be held concurrently. Shadow Medical has brought together domestic and international innovative enterprises to exchange insights and explore the current landscape of digital chronic disease management.Improvement of Medical Service Quality, Enhancement of Patient Adherence, and Healthcare Payment...and other pressing issues, laying a solid foundation for the sustainable delivery of high-quality healthcare.

Experts from China and abroad will discuss, from various perspectives including clinical practice, industry, market research, investment, and users, focusing onEmpowerment through Digital Technologies, Patient Adherence Issues, Healthcare Payment, and Similarities and Differences in Digital Chronic Disease Management Models at Home and Abroadand other issues, exploring the development opportunities and challenges in current medical services and chronic disease management from multi-role and multi-dimensional perspectives.

It is worth noting that at this conference, Jiahui Health will jointly launch a health management service product with MSH China (hereinafter referred to as “MSH”; Chinese name: Wanxinhe). Following this strategic partnership, MSH China will become a health management service provider engaging in strategic collaborations with medical institutions for chronic disease management services.

MSH International, the parent company of MSH China, is a French firm founded in 1974 that specializes in international healthcare design and employee benefits consulting and management. As the Asia-Pacific headquarters of MSH International, MSH China has been deeply entrenched in China’s high-end health insurance services market for over two decades. It is China’s first international health insurance service center and the first to establish a direct-billing medical network in collaboration with top-tier public medical institutions in the country. Boasting a leading domestic medical network and 900,000 partner healthcare institutions worldwide, MSH China serves 3,000 corporate clients and has long maintained a leading position in the high-end medical insurance services market.

On one side of the forum, a “Yao Health” product experience zone was set up, allowing attendees to directly learn about and try out innovative solutions, while also providing opportunities for face-to-face exchanges with medical device manufacturers, healthcare service providers, insurance companies, and experts and scholars, thereby facilitating in-depth resource connectivity.

The digital health wave is surging, and the challenges facing innovative enterprises are becoming increasingly formidable. Yet one thing remains constant: the “patient-centric” philosophy will always be the guiding theme for medical enterprises pursuing innovation-driven development. This is precisely the founding mission and core identity of Singula Health. On June 16, 2023, in a conference pavilion on the Bund in Shanghai—where classic meets modern, and history intertwines with the future—we look forward to meeting you.